-
501
Rheological monitoring of tau protein polymerisation with acoustic waves sensor
Published 2017-03-01Subjects: Get full text
Article -
502
Reducing neonatal Fc receptor binding enhances clearance and brain-to-blood ratio of TfR-delivered bispecific amyloid-β antibody
Published 2024-12-01Subjects: “…Alzheimer’s disease (AD)…”
Get full text
Article -
503
RatDEGdb: a knowledge base of differentially expressed genes in the rat as a model object in biomedical research
Published 2023-12-01Subjects: Get full text
Article -
504
Calcium bridges built by mitochondria-associated endoplasmic reticulum membranes: potential targets for neural repair in neurological diseases
Published 2025-12-01Subjects: “…alzheimer’s disease…”
Get full text
Article -
505
Globular-shaped Aβ oligomers have diverse mechanisms for promoting Aβ aggregations with the facilitation of fibril elongation
Published 2025-02-01Subjects: “…Alzheimer's disease…”
Get full text
Article -
506
Effectiveness and utilization of a cognitive screening program for primary geriatric care
Published 2025-01-01“…Alzheimer’s Research & Therapy…”
Get full text
Article -
507
Timing of risk factors, prodromal features, and comorbidities of dementia from a large health claims case–control study
Published 2025-01-01“…Alzheimer’s Research & Therapy…”
Get full text
Article -
508
Inflammatory biomarkers profiles and cognition among older adults
Published 2025-01-01Get full text
Article -
509
-
510
The regulatory role of cystatin C in autophagy and neurodegeneration
Published 2019-07-01“…It has been suggested that cystatin C plays the primary role in amyloidogenesis and shows promise as a therapeutic agent for neurodegenerative diseases (Alzheimer’s and Parkinson’s diseases). Cystatin C colocalizes with the amyloid β-protein in the brain during Alzheimer’s disease. …”
Get full text
Article -
511
Decoding the molecular, cellular, and functional heterogeneity of zebrafish intracardiac nervous system
Published 2024-12-01Get full text
Article -
512
Enhancing NMDA Receptor Function: Recent Progress on Allosteric Modulators
Published 2017-01-01“…In light of the discovery of NMDAR hypofunction in psychiatric disorders and perhaps Alzheimer’s disease, efforts in boosting NMDAR activity/functions have surged in recent years. …”
Get full text
Article -
513
Phosphodiesterase-5 Inhibitors: Action on the Signaling Pathways of Neuroinflammation, Neurodegeneration, and Cognition
Published 2015-01-01“…Mechanistically, PDE5-Is produce an anti-inflammatory and neuroprotection effect by increasing expression of nitric oxide synthases and accumulation of cGMP and activating protein kinase G (PKG), the signaling pathway of which is thought to play an important role in the development of several neurodiseases, such as Alzheimer’s disease (AD), Parkinson’s disease (PD), and multiple sclerosis (MS). …”
Get full text
Article -
514
Quercetin nanoparticles as a therapeutic approach: pharmacological actions and potential applications in therapy
Published 2024-12-01“…It also highlights their potential as therapeutic agents in treating a wide range of diseases, including Alzheimer’s disease, cancer, and neurodegenerative disorders.…”
Get full text
Article -
515
Genotoxicity Studies of Titanium Dioxide Nanoparticles (TiO2NPs) in the Brain of Mice
Published 2016-01-01“…Moreover, Comet assay revealed the apoptotic DNA fragmentation, while PCR-SSCP pattern and direct sequencing showed point mutation of Presenilin 1 gene at exon 5, gene linked to inherited forms of the Alzheimer’s disease. Therefore, from these findings, the present study concluded that TiO2NPs is genotoxic and mutagenic to brain tissue which in turn might lead to Alzheimer’s disease incidence.…”
Get full text
Article -
516
An overview of methods for the treatment and diagnosis of dementia with Lewy bodies. Clinical case analysis
Published 2020-12-01“…Although DLB is the third most common type of dementia in the elderly, after Alzheimer’s disease and vascular dementia, it is still too rarely diagnosed. …”
Get full text
Article -
517
Oxidative stress induced protein aggregation via GGCT produced pyroglutamic acid in drug resistant glioblastoma
Published 2025-02-01“…Finally, we found increased protein aggregation, GGCT expression, and pyroglutamic acid staining in recurrent GBM patient samples, adjacent non-tumor brain, and Alzheimer’s brains. These findings suggest a new pathway for protein aggregation within drug resistant brain cancer that should be further studied in other brain disorders.…”
Get full text
Article -
518
-
519
Assessing the Impact of Physical Activity on Dementia Progression Using Clustering and the MRI-Based Kullback–Leibler Divergence
Published 2025-01-01“…Dementia, including Alzheimer’s disease, is a neurodegenerative illness characterized by the progressive impairment of cognitive functions, posing a significant global health threat. …”
Get full text
Article -
520
Chemical Profiles and In Vitro Cholinesterase Inhibitory Activities of the Flower Extracts of Cassia spectabilis
Published 2023-01-01“…The water and ethanolic extracts of C. spectabilis flowers displayed potency for Alzheimer’s disease treatment. The presence of piperidine alkaloids in the extract may be responsible for the cholinesterase inhibitory activity. …”
Get full text
Article